{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:13:08Z","timestamp":1787760788410,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nephcure Kidney International"},{"DOI":"10.13039\/100012866","name":"University of Calgary\u2019s Cumming School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Variability exists in regards to corticosteroid prescriptions for children with steroid-sensitive nephrotic syndrome across Canadian sites.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Children\u2019s age and ethnicity are associated with average corticosteroid dose and duration of therapy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Variation observed in corticosteroid prescriptions could be attributed to unmeasured differences between patients.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Variation in dose and duration of corticosteroids for childhood-onset steroid-sensitive nephrotic syndrome occurs worldwide, likely reflecting the evolving evidence on optimal dosing and variable severity of the disease observed between patients. We conducted a study to determine the associations between site, physician, and patient factors, and average daily corticosteroid dose and duration of therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data were derived from the Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project, an observational longitudinal study from 2013 to 2019 of children with nephrotic syndrome involving pediatric nephrologists in 11 sites across Canada. The primary outcome was average daily corticosteroid dose prescribed per episode of proteinuria, reported as mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      prednisone equivalents. Secondary outcome was duration of treatment for each episode of proteinuria in days. Exposure variables were categorized into site-, physician-, and patient-level variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 328 children, median age at enrollment of 4.3 years old (interquartile range [IQR], 3.6), participated and were followed for a median time of 2.62 years (IQR, 2.6). The observed variability in average daily corticosteroid dose and in duration of therapy was mostly attributed to the site where the patient was treated. Accounting for between patient, physician, and site differences, average daily corticosteroid dose decreased with increasing age (beta coefficient, \u22120.07; 95% confidence interval [95% CI], \u22120.09 to \u22120.05],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). African and Indigenous ethnicity was associated with longer treatment duration compared with White patients (beta coefficient: African, 42.29, 95% CI, 7.85 to 76.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.02; Indigenous, 29.65, 95% CI, 2.79 to 56.52,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found practice variation with respect to corticosteroid prescriptions across 11 Canadian sites, and that variation is mostly explained at the site level. Age and ethnicity are important factors to be considered, because they are significantly associated with the average corticosteroid dose and duration of therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0002692021","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T10:51:53Z","timestamp":1632394313000},"page":"1960-1967","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics Associated with Variation in Corticosteroid Exposure in Children with Steroid-Sensitive Nephrotic Syndrome: Results from a Canadian Longitudinal Study"],"prefix":"10.34067","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-4855","authenticated-orcid":false,"given":"Sara","family":"Rodriguez-Lopez","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Stollery Children\u2019s Hospital, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-3118","authenticated-orcid":false,"given":"Rahul","family":"Chanchlani","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, McMaster Children\u2019s Hospital, McMaster University, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-1770","authenticated-orcid":false,"given":"Allison B.","family":"Dart","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Stollery Children\u2019s Hospital, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Lapeyraque","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Pediatric Department, Sainte Justine University Hospital Center, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Tee","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Faculty of Medicine, Dalhousie University, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-7954","authenticated-orcid":false,"given":"Anita","family":"Brobbey","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneka A.","family":"Perinpanayagam","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Samuel","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6604-0652","authenticated-orcid":false,"given":"Alberto","family":"Nettel-Aguirre","sequence":"additional","affiliation":[{"name":"Centre for Health and Social Analytics, National Institute for Applied Statistics Research, University of Wollongong, Wollongong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"B1-20250825","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","article-title":"Nephrotic syndrome in The Netherlands: A population-based cohort study and a review of the literature","volume":"26","author":"El Bakkali","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B2-20250825","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","article-title":"Long-term outcome of primary nephrotic syndrome","volume":"57","author":"Koskimies","year":"1982","journal-title":"Arch Dis Child"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0031-3955(16)32565-2","article-title":"The nephrotic syndrome","volume":"18","author":"Arneil","year":"1971","journal-title":"Pediatr Clin North Am"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/PL00013433","article-title":"Variability among pediatric nephrologists in the initial therapy of nephrotic syndrome","volume":"14","author":"Lande","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00467-009-1282-y","article-title":"Management patterns of childhood-onset nephrotic syndrome","volume":"24","author":"MacHardy","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B7-20250825","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-013-2546-0","article-title":"Substantial practice variation exists in the management of childhood nephrotic syndrome","volume":"28","author":"Samuel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/adc.2007.129957","article-title":"Long-term steroid treatment and growth: A study in steroid-dependent nephrotic syndrome","volume":"95","author":"Simmonds","year":"2010","journal-title":"Arch Dis Child"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00198-013-2466-7","article-title":"Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome","volume":"25","author":"Phan","year":"2014","journal-title":"Osteoporos Int"},{"key":"B12-20250825","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00467-008-1089-2","article-title":"Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: Is it equivalent?","volume":"24","author":"Feber","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front Pediatr"},{"key":"B14-20250825","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/FTD.0000000000000308","article-title":"Population pharmacokinetics of prednisolone in relation to clinical outcome in children with nephrotic syndrome","volume":"38","author":"Teeninga","year":"2016","journal-title":"Ther Drug Monit"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children","volume":"98","year":"1981","journal-title":"J Pediatr"},{"key":"B16-20250825","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002290.pub3","article-title":"Non\u2010corticosteroid treatment for nephrotic syndrome in children","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"B17-20250825","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001533.pub5","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B18-20250825","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney Int"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"key":"B21-20250825","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2215\/CJN.06140420","article-title":"Short-duration prednisolone in children with nephrotic syndrome relapse","volume":"16","author":"Kainth","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B22-20250825","doi-asserted-by":"crossref","first-page":"e018148","DOI":"10.1136\/bmjopen-2017-018148","article-title":"REducing STEroids in Relapsing Nephrotic syndrome: The RESTERN study-protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study","volume":"7","author":"Schijvens","year":"2017","journal-title":"BMJ Open"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0002692021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:02:38Z","timestamp":1786478558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0002692021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0002692021","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"2021-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}